期刊文献+

动物活体淋巴系统99~mTc-DX显像的实验研究 被引量:1

STUDIES OF 99 ~MTc-DX IN ANIMAL SCINTIGRAPHY
下载PDF
导出
摘要 应用自己研制的99~mTc—DX淋巴管显像药盒,对不同处理的动物进行了病理与显像结果分析。选用DX分子量为48,000。注射剂量0.1ml,放射强度0.5mci。大鼠注射尾静脉,小鼠于趾间皮下注射。用单光子发射计算机断层仪(SPECT)分别观察显像情况,并进行病理对比。结果表明:大鼠尾静脉注射后,肝、肾显像清晰。正常小鼠显像淋巴链完整,影像对称;患瘤小鼠局部淋巴通常受阻,淋巴链不完整,影像两侧不对称。显像结果与病理观察相同。研究结果提示:99~mTc—DX药盒除适用于临床推广应用外,还适用于实验动物肿瘤模型的诊断、肿瘤淋巴转移的预测、肿瘤术后的观察及肝癌导向治疗等实验研究。 We observed image state of the rats and mice with 99 ~mTc-DX thatwere made by ourself. The usefulness of 99 ~mTc-Dextran with a molecular weight of48,000, injection size of 0.1 ml(0.2~0.5mci). Rat injected site from the tail vein,mice injected site from the skin of hind or front interdigits. the animal observedimaging with SPECT. The results yielded high-quality scintigraphy of the liver,kidney in rat and radionuclide of the mouse. We conclude that 99~mTc-DX is a very promising agent for lymphoscintigraphy.Animals as well as pilot studies in man produced high-contrast images of the lymphsystem. The potential value of this new radiopharmaceutical for diagnosis and follow-up of animal with cancer, cancer lymph metastasis, and animal laboratory studies oftargeting therapy on liver cancer.
出处 《实验动物与比较医学》 CAS 1991年第1期11-13,10,共4页 Laboratory Animal and Comparative Medicine
关键词 99 ~mTc-DX LYMPHOSCINTIGRAPHY TARGETING therapy 99 ~mTc-DX Lymphoscintigraphy Targeting therapy
  • 相关文献

参考文献3

  • 1汤钊猷.基础理论和技术的进展推动肝癌临床研究[J].肿瘤,1989,9(4):188-190. 被引量:1
  • 2管昌田,谭天秩,邓候富,陈佩珍.Tc-葡聚糖乳内淋巴显像及其临床评价[J]华西医科大学学报,1988(04).
  • 3Dr. Meral T. Ercan,Martin Schneidereit,Reingard Senekowitsch,Heinz Kriegel. Evaluation of 99mTc-dextran as a lymphoscintigraphic agent in rabbits[J] 1985,European Journal of Nuclear Medicine(2-3):80~84

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部